REMIFENTANIL B.BRAUN 1 MG Izrael - angleščina - Ministry of Health

remifentanil b.braun 1 mg

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 1 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

REMIFENTANIL B.BRAUN 2 MG Izrael - angleščina - Ministry of Health

remifentanil b.braun 2 mg

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 2 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

REMIFENTANIL B.BRAUN 2 MG Izrael - angleščina - Ministry of Health

remifentanil b.braun 2 mg

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 2 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

REMIFENTANIL B.BRAUN 5 MG Izrael - angleščina - Ministry of Health

remifentanil b.braun 5 mg

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 5 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

REMIFENTANIL B.BRAUN 5 MG Izrael - angleščina - Ministry of Health

remifentanil b.braun 5 mg

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 5 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

VORICONAZOLE-AFT voriconazole 200 mg powder for injection vial Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

voriconazole-aft voriconazole 200 mg powder for injection vial

aft pharmaceuticals pty ltd - voriconazole, quantity: 200 mg - injection, powder for - excipient ingredients: nitrogen; water for injections; sulfobutyl betadex sodium - voriconazole ? aft is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Remifentanil 1 mg powder for concentrate for solution for injection or infusion Irska - angleščina - HPRA (Health Products Regulatory Authority)

remifentanil 1 mg powder for concentrate for solution for injection or infusion

pinewood laboratories ltd, - remifentanil hydrochloride - powder for concentrate for solution for injection/infusion - 1 milligram(s) - opioid anesthetics; remifentanil

Remifentanil 2 mg powder for concentrate for solution for injection or infusion Irska - angleščina - HPRA (Health Products Regulatory Authority)

remifentanil 2 mg powder for concentrate for solution for injection or infusion

pinewood laboratories ltd, - remifentanil hydrochloride - powder for concentrate for solution for injection/infusion - 2 milligram(s) - opioid anesthetics; remifentanil

Remifentanil 5 mg powder for concentrate for solution for injection or infusion Irska - angleščina - HPRA (Health Products Regulatory Authority)

remifentanil 5 mg powder for concentrate for solution for injection or infusion

pinewood laboratories ltd, - remifentanil hydrochloride - powder for concentrate for solution for injection/infusion - 5 milligram(s) - opioid anesthetics; remifentanil

ERYTHROMYCIN-LINK erythromycin 1g (as lactobionate) powder for injection vial Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

erythromycin-link erythromycin 1g (as lactobionate) powder for injection vial

link medical products pty ltd t/a link pharmaceuticals - erythromycin lactobionate, quantity: 1.4882 g/g (equivalent: erythromycin, qty 1 g) - injection, powder for - excipient ingredients: - oral erythromycin is not considered to be the antibiotic of choice in severely ill patients.,erythromycin-link (sterile erythromycin lactobionate) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. intravenous therapy should be replaced by oral administration at the appropriate time.,? upper respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae); haemophilus influenzae (many strains of h. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved).,? lower respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae).,? respiratory tract infections due to mycoplasma pneumoniae.,? skin and s